In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse

被引:41
作者
Embury, SH
Mohandas, N
Paszty, C
Cooper, P
Cheung, ATW
机构
[1] San Francisco Gen Hosp, Div Hematol, San Francisco, CA 94110 USA
[2] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA
[3] Univ Calif San Francisco, San Francisco, CA 94110 USA
[4] Lawrence Berkeley Lab, Dept Life Sci, Berkeley, CA 94720 USA
[5] Amgen Inc, Dept Mol Genet, Thousand Oaks, CA 91320 USA
[6] Univ Calif Davis, Med Ctr, Dept Med Pathol, Sacramento, CA 95817 USA
关键词
D O I
10.1172/JCI5977
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The accepted importance of circulatory impairment to sickle cell anemia remains to be verified by in vivo experimentation. Intravital microscopy studies of blood flow in patients are limited to circulations that can be viewed noninvasively and are restricted from deliberate perturbations of the circulation. Further knowledge of sickle blood flow abnormalities has awaited an animal model of human sickle cell disease. We compared blood flow in the mucosal-intestinal microvessels of normal mice with that in transgenic knockout sickle cell mice that have erythrocytes containing only human hemoglobin S and that exhibit a degree of hemolytic anemia and pathological complications similar to the human disease. In sickle cell mice, in addition to seeing blood flow abnormalities such as sludging in all microvessels, we detected decreased blood flow velocity in venules of all diameters. Flow responses to hyperoxia in both normal and sickle cell mice were dramatic, but opposite: Hyperoxia promptly slowed or halted flow in normal mice but markedly enhanced flow in sickle cell mice. Intravital microscopic studies of this murine model provide important insights into sickle cell blood flow abnormalities and suggest that this model can be used to evaluate the causes of abnormal flow and new approaches to therapy of sickle cell disease.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 38 条
[31]   Toxic oxidant species and their impact on the pulmonary surfactant system [J].
Putman, E ;
vanGolde, LMG ;
Haagsman, HP .
LUNG, 1997, 175 (02) :75-103
[32]   PERIODIC MICROCIRCULATORY FLOW IN PATIENTS WITH SICKLE-CELL DISEASE [J].
RODGERS, GP ;
SCHECHTER, AN ;
NOGUCHI, CT ;
KLEIN, HG ;
NIENHUIS, AW ;
BONNER, RF .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (24) :1534-1538
[33]   Knockout-transgenic mouse model of sickle cell disease [J].
Ryan, TM ;
Ciavatta, DJ ;
Townes, TM .
SCIENCE, 1997, 278 (5339) :873-876
[34]   INVIVO AND INVITRO MEASUREMENTS OF RED-CELL VELOCITY UNDER EPIFLUORESCENCE MICROSCOPY [J].
SEKI, J ;
LIPOWSKY, HH .
MICROVASCULAR RESEARCH, 1989, 38 (01) :110-124
[35]  
TRUDEL M, 1990, NOUV REV FR HEMATOL, V32, P407
[36]   TOWARDS A TRANSGENIC MOUSE MODEL OF SICKLE-CELL DISEASE - HEMOGLOBIN SAD [J].
TRUDEL, M ;
SAADANE, N ;
GAREL, MC ;
BARDAKDJIANMICHAU, J ;
BLOUQUIT, Y ;
GUERQUIN KERN, JL ;
ROUYERFESSARD, P ;
VIDAUD, D ;
PACHNIS, A ;
ROMEO, PH ;
BEUZARD, Y ;
COSTANTINI, F .
EMBO JOURNAL, 1991, 10 (11) :3157-3165
[37]   ERYTHROCYTE VELOCITY MEASUREMENT IN MICROVESSELS BY A 2-SLIT PHOTOMETRIC METHOD [J].
WAYLAND, H ;
JOHNSON, PC .
JOURNAL OF APPLIED PHYSIOLOGY, 1967, 22 (02) :333-&
[38]  
ZIPURSKY A, 1992, AM J PEDIAT HEMATOL, V14, P222